Erminia Manfrin
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 27
- HER2/EGFR in Cancer Research 11
- Cancer Research top 5%
- Breast Cancer Treatment Studies 18
- Cancer Genomics and Diagnostics 7
- Physiology top 5%
-
- Breast Lesions and Carcinomas 11
-
- Pancreatitis Pathology and Treatment 14
-
- Neuroendocrine Tumor Research Advances 13
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Franco BonettiGuido MartignoniAndrea RemoChiara ColatoStefano Francesco CrinòLaura BernardoniMaurizio PeaArmando Gabbrielli
- Partner nations
- ItalySpainUnited States
In The Last Decade
Erminia Manfrin
97 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 96
- Oncology 1.4k
- Cancer Research 466
- Pulmonary and Respiratory Medicine 698
- Physiology 455
- Pathology and Forensic Medicine 310
Countries citing papers authored by Erminia Manfrin
This map shows the geographic impact of Erminia Manfrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erminia Manfrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erminia Manfrin more than expected).
Fields of papers citing papers by Erminia Manfrin
This network shows the impact of papers produced by Erminia Manfrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erminia Manfrin. The network helps show where Erminia Manfrin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erminia Manfrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 4 | |
| 7 | 2019 | 29 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 9 | |
| 11 | 2015 | 19 | |
| 12 | 2015 | 57 | |
| 13 | 2014 | 6 | |
| 14 | 2011 | 11 | |
| 15 | 2011 | 52 | |
| 16 | 2010 | 12 | |
| 17 | 2009 | 5 | |
| 18 | 2009 | 87 | |
| 19 | 2009 | 21 | |
| 20 | Tumors characterized by the presence of HMB45-positive perivascular epithelioid cell (PEC) - A novel entity in surgical pathology | 1997 | 7 |
About Erminia Manfrin
Erminia Manfrin is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 99 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (27 papers), Breast Cancer Treatment Studies (18 papers), Pancreatitis Pathology and Treatment (14 papers), Neuroendocrine Tumor Research Advances (13 papers), Breast Lesions and Carcinomas (11 papers), HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (466 citations) and Pulmonary and Respiratory Medicine (698 citations). Erminia Manfrin has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Franco Bonetti, Guido Martignoni, Andrea Remo, Chiara Colato, Stefano Francesco Crinò, Laura Bernardoni, Maurizio Pea, Armando Gabbrielli, Massimo Pancione and Alice Parisi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.